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Prevalence of Hemolysin Genes and Comparison of ehxA Subtype
Patterns in Shiga Toxin-Producing Escherichia coli (STEC) and NonSTEC Strains from Clinical, Food, and Animal Sources
Sandra C. Lorenz,a,b Insook Son,a Anna Maounounen-Laasri,a Andrew Lin,c Markus Fischer,b Julie A. Kasea
U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Division of Microbiology, College Park, Maryland, USAa; University of Hamburg,
Hamburg School of Food Science, Institute of Food Chemistry, Hamburg, Germanyb; U.S. Food and Drug Administration, San Francisco District Laboratory, Alameda,
California, USAc

Shiga toxin-producing Escherichia coli (STEC) belonging to certain serogroups (e.g., O157 and O26) can cause serious conditions like hemolytic-uremic syndrome (HUS), but other strains might be equally pathogenic. While virulence factors, like stx and
eae, have been well studied, little is known about the prevalence of the E. coli hemolysin genes (hlyA, ehxA, e-hlyA, and sheA) in
association with these factors. Hemolysins are potential virulence factors, and ehxA and hlyA have been associated with human
illness, but the significance of sheA is unknown. Hence, 435 E. coli strains belonging to 62 different O serogroups were characterized to investigate gene presence and phenotypic expression of hemolysis. We further investigated ehxA subtype patterns in E.
coli isolates from clinical, animal, and food sources. While sheA and ehxA were widely distributed, e-hlyA and hlyA were rarely
found. Most strains (86.7%) were hemolytic, and significantly more hemolytic (95%) than nonhemolytic strains (49%) carried
stx and/or eae (P < 0.0001). ehxA subtyping, as performed by using PCR in combination with restriction fragment length polymorphism analysis, resulted in six closely related subtypes (>94.2%), with subtypes A/D being eae-negative STECs and subtypes
B, C, E, and F eae positive. Unexpectedly, ehxA subtype patterns differed significantly between isolates collected from different
sources (P < 0.0001), suggesting that simple linear models of exposure and transmission need modification; animal isolates carried mostly subtypes A/C (39.3%/42.9%), food isolates carried mainly subtype A (81.9%), and clinical isolates carried mainly
subtype C (66.4%). Certain O serogroups correlated with particular ehxA subtypes: subtype A with O104, O113, and O8; B exclusively with O157; C with O26, O111, and O121.

N

on-O157 Shiga toxin-producing Escherichia coli (STEC) became a focus of attention based on the continuously increasing numbers of non-O157-related illnesses reported worldwide
(1–5). Over 100 different O serogroups are associated with Shiga
toxin production, although not all STEC strains are pathogenic to
humans (2, 6). However, some STEC strains are as virulent as
O157:H7 and have caused outbreaks of severe illness (7, 8), including hemorrhagic colitis (HC), hemolytic-uremic syndrome
(HUS), and even death (8–10). Relatively few organisms of these
strains are needed to cause disease, and the consumption of contaminated foods or drinking water or close contact with STECinfected animals have been shown to be important transmission
routes for STEC infections in humans (11–13). Domestic and wild
ruminants, especially cattle, are natural reservoirs of STEC that
shed the bacteria with their feces in the environment (12). While
STEC-infected animals usually do not show signs of disease and
can be included in food production, STEC from these animals can
be highly virulent to humans. Consumption of products of animal
origin, such as meat, therefore presents a risk factor for STEC
infection. Furthermore, most fresh produce is grown in close contact with the ground and is vulnerable to E. coli contamination
from livestock area runoff, manure when used as fertilizer, and
field intrusion of wildlife (5, 11, 14, 15).
While O157:H7 is well characterized and widely accepted as a
human pathogen, non-O157 E. coli strains are very heterogenous
in their virulence attributes. Certain serogroups are known to
cause HC and HUS (e.g., O26 and O111), and O45 is associated
with HC (1, 2); however, other serogroups (O91, O113, and
O128) may cause HC and HUS but are less commonly isolated (1,
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6). Specific virulence markers that could definitely characterize
STEC isolates as pathogenic have not been universally agreed
upon. Shiga toxin (stx1 and stx2), its variants, and the protein
intimin (encoded by the eae allele), which is involved in attachment of the organisms to and effacing of gut mucosal cells, are
only a few examples of established virulence factors (16–21). Also,
several different types of hemolysin genes have been identified in
various bacterial species and are often regarded as major virulence
factors (22, 23). Four types of hemolysin have been identified in E.
coli: alpha-hemolysin (hlyA), plasmid- and phage-carried enterohemolysin (ehxA, e-hlyA), and silent hemolysin (sheA). The plasmid-carried ehxA and hlyA belong to the RTX (repeat in toxin)
family, which are widespread among Gram-negative pathogens
and lyse erythrocytes from different mammalian species (24–26).
The presence of enterohemolysin is only detected on washed
sheep blood agar after overnight incubation at 37°C, as opposed to
alpha-hemolysin, which is detectable after 3 to 6 h of incubation
on standard blood agar plates (25, 27, 28). hlyA, found on the
pathogenicity island (29), is produced by many E. coli strains that
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are associated with urinary tract infections (30–32). The ehxA
gene, located on the large enterohemorrhagic E. coli virulence
plasmid (28, 33), is frequently associated with diarrheal disease
and HUS (34, 35). Since the detection of enterohemolysin is relatively easy due to its hemolytic activity, and its presence correlates
with that of Shiga toxin, it has been suggested as an epidemiological marker for the rapid and simple detection of STEC strains (28,
36). Six genetically distinct ehxA subtypes (A to F) have been identified in E. coli by using PCR and restriction fragment length polymorphism (RFLP) analysis (37).
The bacteriophage-associated enterohemolysin (e-hlyA) is genetically unrelated to the plasmid-carried ehxA (38–40). It was
suggested that the e-hlyA determinant does not encode a hemolysin, per se, as reported in earlier studies (38, 39), but instead causes
the release of the silent hemolysin by lysis of the bacterial cells (40).
The silent hemolysin (sheA), also called cytolysin A, encodes a
pore-forming toxin (41, 42) not related to the RTX family (43, 44).
It was first found in E. coli strain K-12 (45, 46), but it is also present
in E. coli O157:H7 (47), as well as in other enteropathogenic E. coli
strains (48). In cultured mammalian cells, cytotoxicity and inducement of macrophage apoptosis through the action of the silent hemolysin have been reported (49, 50). These findings indicate that sheA might contribute to the pathogenicity of E. coli
strains, although its presence in correlation with the appearance of
extraintestinal infections has yet not been clarified. Hemolytic activity due to the silent hemolysin can be only detected under
certain conditions, for example, if sheA is present on high-copynumber plasmids or when certain regulator genes are overexpressed (51, 52).
The objective of this study was to investigate the prevalence of
hemolytic phenotypes and/or genotypes (ehxA, e-hlyA, sheA, and
hlyA) in correlation with the potential pathogenicity of various E.
coli strains, as judged by the presence or absence of stx and eae.
Furthermore, this study aimed to investigate the distribution of
ehxA subtypes within and between isolates from clinical, food, and
animal sources, as well as different O serogroups from different
geographical areas. By including isolates from ground beef and
fresh produce, food products which have been important transmission vehicles of E. coli infections in humans in the past (3–5,
11, 13, 53), we were able to investigate, by using ehxA subtype
occurrence, a potential linear flow of infection originating from
farm animals and food to ill individuals.
MATERIALS AND METHODS
Bacterial strains. A total of 435 E. coli isolates from different sources (154
clinical, 200 food, 58 animal, nine environmental, and 14 unidentified
source) and geographical areas were investigated. The strains belonged to
62 different O serogroups, including the 10 most clinically relevant STEC
serogroups (O26, O103, O111, O145, O157, O91, O113, O128, O45, and
O121). The 435 strains used in this study were kindly provided by the
following (see also Table S1 in the supplemental material): 46 E. coli
strains from various sources (water, animal, and clinical) from the E. coli
Reference Center at Pennsylvania State University (54), 67 ground beef
isolates from Mick Bosilevac (USDA U.S. Meat Animal Research Center,
Clay Center, NE) (55), 101 agricultural food isolates from Shanker Reddy
(USDA AMS Microbiological Data Program [MDP]), 32 food isolates
from an FDA Center for Food Safety and Applied Nutrition (CFSAN)sponsored produce survey, 99 isolates of different sources from the STEC
Center at Michigan State University (www.shigatox.net), five strains of
different sources obtained through Lydia V. Rump (University of Maryland, Department of Nutrition and Food Science, College Park, MD), and
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seven bovine isolates, five clinical strains, and strain AD4001-1B were
provided by Andrew Lin (FDA San Francisco District Laboratory, Alameda, CA). Of the clinical isolates, 32 were obtained from Alifiya Ghadiali
(FDA CFSAN, College Park, MD), and 40 were provided by Nancy
Strockbine (Centers for Disease Control and Prevention, Atlanta, GA).
Potential duplicate strains (e.g., strains originating from the same outbreak) were removed according to the available information, such as clinical outcome, host, geographical location, date of isolation, pulsed-field
gel electrophoresis (PFGE) pattern, and the virulence gene pattern confirmed in this study.
Preparation of template DNA and culture conditions for hemolysin
expression. Bacterial strains were grown aerobically for 18 to 24 h on
tryptic soy agar (TSA) at 37°C. One colony was transferred into 1.5 ml of
tryptic soy broth and incubated for another 18 to 24 h at 37°C in a shaking
incubator. DNA was extracted using the DNeasy blood and tissue kit
(Qiagen Inc., Valencia, CA) as per the manufacturer’s instructions for
Gram-negative bacteria. Template DNA was stored at ⫺20°C until use.
Hemolytic activity was verified on STEC heart infusion washed blood
agar with mitomycin C (SHIBAM) as described previously (56). A single
colony of each strain was inoculated from TSA onto SHIBAM and incubated for 6 and 24 h at 37°C. The agar plates were examined after 6 h for
indications of alpha-hemolysin effects and after 24 h for all hemolysin
types.
Detection of established and putative virulence factors. Each strain
was screened for the targets stx1, stx2, eae, uidA, ehxA, hlyA, e-hlyA, and
sheA by using PCR (C1000 thermal cycler; Bio-Rad Laboratories Inc.,
Hercules, CA). One microliter of DNA template was added to a 24-l PCR
mixture containing 0.6 units HotStarTaq DNA polymerase (Qiagen Inc.),
2.5 l 10⫻ PCR buffer with 15 mM MgCl2 (Qiagen Inc.), 0.2 mM deoxynucleoside triphosphates (Invitrogen Life Technologies, Grand Island,
NY), and 4 M of each primer (IDT, Inc., Coralville, IA, manufactured
with standard desalting) (Table 1). The template was denatured for 15
min at 95°C, followed by 25 cycles of denaturation at 95°C for 1 min,
annealing at 54°C for 1 min, and extension at 72°C for 1 min, and a final
extension step at 72°C for 5 min. All products were electrophoresed on
precast 2% agarose gels containing ethidium bromide (E-Gel; Invitrogen
Life Technologies) and visualized on a UV transilluminator (G:Box; Imgen Technologies, Alexandria, VA).
O serogroup identification. Serotype information for all 435 E. coli
isolates used in this study was provided by the contributors of the strains.
However, serogroups O26, O45, O91, O103, O104, O111, O113, O121,
O128, O145, and O157 were confirmed via a Luminex microbead-based
suspension array with the Bio-Plex 200 instrument (Luminex Corporation, Austin, TX) as described previously (57). Antisera from Statens Serum Institut (MiraVista, Indianapolis, IN) were used to confirm the BioPlex results (58) for non-O157 E. coli (except serogroup O104), and the E.
coli O157:H7 latex test kit (Remel, Lenexa, KS) was used to confirm O157.
Molecular characterization of ehxA subtypes. ehxA subtype identification via RFLP analysis was conducted for all E. coli strains that were ehxA
PCR positive. PCR amplification of the complete ehxA gene was performed with 1 l template DNA and 0.6 M of each primer (ehxA ext.
F/R) (Table 1). Amplification of the ehxA gene for ehxA subtype D strains
did not result in PCR products; hence, the full-length ehxA gene of subtype D strains was amplified using the primers (ehxA RFLP F/R) described
by Cookson et al. (37) (Table 1). Platinum PCR SuperMix High Fidelity
(Invitrogen Life Technologies) was added to a total of 20 l. Amplification
and digestion with TaqI (Invitrogen Life Technologies) was conducted as
described previously (37) with the following adjustments: an initial denaturing step at 95°C for 2 min and polymerization for 3.5 min at 72°C.
Products were then electrophoresed and visualized on a UV transilluminator as described previously. For better amplicon separation and exact
size determination, 1-l aliquots of the digested PCR products were analyzed on an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA).
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TABLE 1 PCR Primers used in this study for detection of target genes and sequencing analysis
Amplicon
size (bp)

Reference or
source

GACTTCTCGACTGCAAAGAC
TGTAACCGCTGTTGTACCTG

306

Son et al.a

stx2 F
stx2 R

CCCGGGAGTTTACGATAGAC
ACGCAGAACTGCTCTGGATG

482

Son et al.

Intiminb

eae F
eae R

GCGCGTTACATTGACTCCCG
CCATTTGCTGGGCGCTCATC

245

Son et al.

uidA

uidA F
uidA R

GGTCACTCATTACGGCAAAG
CAGTTCAACGCTGACATCAC

379

Son et al.

Enterohemolysin (plasmid)

ehxA F
ehxA R

TCTGTATCTGCGGGAGTTAG
CAACGTGCTCAAACATAGCC

136

Son et al.

Silent hemolysin

sheA F
sheA R

GAGGCGAATGATTATGACTG
ACTTCAGGTACCTCAAAGAG

920

74

Alpha-hemolysin

hlyA F
hlyA R

GTCTGCAAAGCAATCCGCTGCAAATAAA
CTGTGTCCACGAGTTGGTTGATTAG

561

74

Enterohemolysin (phage)

ehlyA F
ehlyA R

TCGCAATCACATCACAACC
CCAGCAGTTCGTCATCATCTGAA

810

74

Complete ehxA gene for RFLP
and sequencing

ehxA ext. F
ehxA ext. R

CAGGCAATACCATCATGAAC
GTGCATACAGACTATTATGAG

3,166

Present study

Complete ehxA gene for
subtype D

ehxARFLP F
ehxARFLP R

ATGACAGTAAATAAAATAAAGAAC
TCAGACAGTTGTCGTTAAAGTTG

2,997

37

Internal sequencing primers for
complete ehxA gene

ehxA Seq R1

TGAGCCAAGCTGGTTAAGCT

ehxA Seq F2
ehxA Seq R2

GGCTCTTGATGAATTGCTGAG
ATTGTTGTCAGGGCTGCATC

633

Present study

ehxA Seq F3
ehxA Seq R3

GTCTGATCACATCGGCTGTT
GTGTAAACTCCTTCGGTTGA

642

Present study

ehxA Seq F4
ehxA Seq R4

GGGATGAGAAGATCGGTGAAC
CCTACTGACACCTCCTGTTC

625

Present study

ehxA Seq F5
ehxA Seq R5

CCGTATCTTATAATAAGACGG
CCTCCTTCATCTGCAATTG

670

Present study

ehxA Seq F6

CTGACAGGAGGAAGCGGTAATG

Target

Primer name

Sequence (5=–3=)

Shiga toxin 1

stx1 F
stx1 R

Shiga toxin 2

Present study

Present study

a

I. Son, R. Binet, A. Lin, T. S. Hammack, and J. A. Kase, submitted for publication.
b
The eae primers were tested to include 15 eae variants.

Sequencing of the ehxA gene. The full-length ehxA gene of 12 ehxApositive isolates—two of each of the six ehxA subtypes—was sequenced via standard DNA sequencing through a commercial facility
(MCLAB, South San Francisco, CA). The ehxA gene was amplified
using the primers described earlier (ehxA ext. F/R and ehxA RFLP F/R
for subtype D strains) (Table 1). PCR products were purified using the
QIAquick PCR purification kit (Qiagen Inc.) as per the manufacturer’s
instruction using a microcentrifuge. Sequencing was performed with
10 internally designed primers (Table 1), as well as the two primers
flanking the ehxA gene.
Sequencing and phylogenetic analysis. CLC Main Workbench 6.7.2
(CLC bio, Cambridge, MA) was used for editing DNA sequences. The
phylogenetic tree was compiled using MEGA 4.0.2 (59, 60) with the
neighbor-joining method (61) and the maximum composite likeli-
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hood method for determination of evolutionary distances (62). Sequences were aligned in MEGA 4.0.2 using ClustalW. The percent
nucleotide sequence identity of the ehxA sequences was calculated
using CLC Main Workbench 6.7.2.
Statistical analysis. The significance of observed differences in the
pattern of ehxA subtypes among ehxA-positive isolates obtained from
different sources (clinical, food, and animal), as well as observed differences in frequencies of isolates carrying one or more virulence factors
(stx1, stx2, or eae) among hemolytic versus nonhemolytic isolates were
evaluated by using Fischer’s exact test. Differences in virulence factor
carriage were evaluated both overall and with respect to each source type
separately. All calculations were performed using the R programming
language (63). An ␣ level of 0.05 was used as the criterion for statistical
significance.
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positive clinical isolates belonged to subtype C (66.4%; 75) (Table
3). Overall, all subtypes were found more or less in all categories of
isolates, except for subtype D (2.6%, 4), which was exclusively
found in food isolates (alfalfa sprouts [1], lettuce [2], and ground
beef [1]), and subtype E (1.8%; 2), which was found only in E. coli
strains isolated from ill individuals (Table 3). Furthermore, specific ehxA subtypes were not related to particular animal hosts,
food products, or a specific clinical outcome (Fig. 1, 2, and 3).
Distribution of O serogroups and association with ehxA subtypes. Overall, 259 (59.5%) of the 435 E. coli isolates used in this
study were serotyped as O26 (30 isolates), O45 (11), O91 (17),
O103 (29), O104 (50), O111 (29), O113 (19), O121 (17), O128
(10), O145 (22), O157 (9) or O8 (16). The O serogroup for 62
(14.3%) strains was not determined or not provided. Of the remaining 114 (26.2%) strains, five each were of serogroups O1,
O163, and O168, and six each were of serogroups O22, O116, and
O174; the rest belonged to different serogroups associated with
less than five strains. In this study, 130 (84.4%) of the 154 clinical
and 52 (89.7%) of the 58 animal isolates, but only 40 (20.0%) of
the 200 food isolates, were of the clinically important serogroups
(O26, O45, etc.). Certain O serogroups were associated with particular ehxA subtypes. All ehxA-positive isolates of serogroups
O26, O111, and O121 carried ehxA subtype C regardless of source,
whereas all ehxA-positive isolates of serogroups O104, O113, and
O8 were of ehxA subtype A. ehxA subtype B exclusively corresponded to E. coli strains of serogroup O157, and ehxA subtype F
was found in all ehxA-positive isolates of serogroup O45. Other
serogroups corresponded to different ehxA subtypes, with serogroup O91 being of ehxA subtypes A and C, serogroup O145 being
of subtypes C and E, and O103 being of subtypes F and C.
Sequencing analysis and phylogenetic profiling of ehxA subtypes. Twelve ehxA genes, two of each of the six ehxA subtypes,
were fully sequenced and aligned along with 11 ehxA sequences
published by Cookson et al. (37). Based on the 23 ehxA sequences,
a phylogenetic tree was generated using the neighbor-joining
method with MEGA 4.0. Phylogenetic profiling showed a close
relationship between eae-positive ehxA subtype B, C, and F
strains, while eae-negative subtype A strains formed a distinct
group with subtype E strains. The latter were associated with eaepositive STEC isolates in our study, but they can be eae negative as
well (37). ehxA subtype D strains (eae negative) formed the most
divergent subdivision, one well separated from the other subtypes
(Fig. 4). Pairwise comparison analysis of the 23 ehxA sequences
revealed a percent nucleotide sequence identity of 94.2% to 96.4%
between ehxA subtype D and the remaining five ehxA subtypes.

TABLE 2 Prevalence of ehxA gene among E. coli strains from clinical,
food, animal, and unidentified sources

ehxA
genotype

Total no.
(%) of
strains with
genotype

Positive
Negative

301 (69.2)
134 (30.8)a

No. (%) of strains with ehxA genotype isolated
from source
Clinical

Food

Animal

Unidentified

113 (73.4)
41 (26.6)

155 (77.5)
45 (22.5)

28 (48.3)
30 (51.7)

5 (35.7)
9 (64.3)

a

Nine ehxA-negative water isolates were included in the analysis, to represent the total
of 435 E. coli isolates investigated in the study.

RESULTS

ehxA PCR-RFLP subtyping. ehxA-positive E. coli strains were
subtyped by PCR-RFLP. Overall, 301 (69.2%) of the 435 E. coli
isolates investigated were ehxA positive (Table 2). The majority
(85.0%; 96/113) of the ehxA-positive clinical isolates carried stx
and eae, while almost the same proportion (84.5%; 131/155) of the
ehxA-positive food isolates carried only stx. The majority of the
ehxA-positive strains isolated from animal sources carried stx and
eae (60.7%; 17/28) or stx only (35.7%; 10/28) (Table 3). The five
ehxA-positive E. coli strains isolated from unidentified sources
were all positive for stx and eae, except for one strain which was
only eae positive.
For the PCR step, an attempt was made to use the primers
described by Cookson and colleagues (37), but not all ehxA-positive isolates investigated in this study were detected. Hence, a new
primer pair located just outside the ehxA gene was designed, yet
the ehxA RFLP profiles obtained appeared as described previously
(37). Six distinct (A, B, C, D, E, and F) ehxA subtypes were obtained by PCR-RFLP. Among a total of 301 ehxA-positive E. coli
strains, the majority were represented by ehxA subtype A (50.8%),
followed by subtypes C (36.2%) and F (8.0%). ehxA subtypes B
(3.0%), D (1.3%), and E (0.7%) were detected less frequently (Table 3). The six ehxA subtypes were subdivided into eae-negative
and eae-positive STEC strains; subtypes A and D were eae negative, except for one subtype A strain (an animal isolate) that was
eae positive, and subtypes B, C, E, and F were eae-positive strains.
Three subtype C strains (two clinical and one animal isolate) and
one subtype B strain (unidentified source) were non-STEC strains
but eae positive. ehxA subtype patterns differed significantly between isolates collected from different sources (P ⬍ 0.0001).
While the animal isolates could be divided into subtypes A
(39.3%; 11) and C (42.9%; 12) and the food isolates were mostly
associated with subtype A (81.9%; 127), the majority of the ehxA-

TABLE 3 Virulence factors (stx only, stx and eae, or eae only) associated with ehxA subtypes of E. coli strains from clinical, food, animal, and
unidentified sources
No. of strainsa with virulence factor(s) in isolates from source
ehxA
subtype

No. (%) of strains
with subtype

A
B
C
D
E
F

153 (50.8)
9 (3.0)
109 (36.2)
4 (1.3)
2 (0.7)
24 (8.0)

a

Clinical
stx

Food
stx/eae

eae

15

stx

Animal
stx/eae

eae

stx/eae

eae

10
2
19

1
1
11

1

3

4

127
5
73

2

Unidentified

stx

stx

stx/eae

eae
1

3

4
2
16

1

The values listed in bold correspond to the predominant/unique ehxA subtype(s) in each category of isolate.
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FIG 1 Distribution of clinical isolates to ehxA subtypes and ehxA-negative samples in association with the available clinical data. Values in parentheses are the
total numbers of strains; percentages were calculated based on the total number of clinical isolates (n ⫽ 154).

The sequence similarity of non-subtype D ehxA subtypes was
ⱖ97.3%.
Hemolysin gene prevalence and correlation with hemolytic
expression. The ability of certain E. coli strains to lyse erythrocytes
of mammalian species is termed hemolysis (27), and the use of
SHIBAM proved to be an excellent medium for hemolysis detection for all types of hemolysins (56, 64). The degree of hemolysis
varied by strain, from large and clear zones to turbid and smaller
zones of hemolysis surrounding single colonies, as noted by others
(25, 37, 65). Largely, the different degrees of hemolysis could not
be linked to a particular hemolysin type or ehxA subtype, except
for the alpha-hemolytic strains, which characteristically showed
strong lysis and visible clearing on SHIBAM (27). Overall, 301
(69.2%) of the 435 E. coli strains were positive for ehxA, 408
(93.8%) were positive for sheA, 22 (5.1%) were positive for e-hlyA,
and 12 (2.8%) were alpha-hemolytic. sheA was present mainly in
correlation with other hemolysins, but 63 (16.7%) of the hemolytic strains carried sheA only. The phage-carried enterohemolysin
(e-hlyA) was found in less than 6% of the strains and was mainly
associated with the presence of ehxA and sheA. Generally, hemolytic activity could be attributed to the different types of hemolysins investigated in this study; all 377 hemolytic E. coli strains
carried at least one hemolysin gene. Of the 57 nonhemolytic
strains, two carried ehxA, but no hemolytic phenotype was detected.
Hemolytic expression in association with virulence factors.
Overall, 377 (86.7%) of the 435 E. coli strains investigated in this
study showed hemolytic activity on washed sheep blood agar after
24 h of incubation at 37°C. Significantly more hemolytic strains
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(95.0%; 358/377) were associated with stx and/or eae positivity
than among nonhemolytic strains (49.1%; 28/57) (P ⬍ 0.0001)
(Table 4; Fig. 5). Of the 19 hemolytic strains (5.0%) that lacked the
presence of Shiga toxin and/or intimin, two strains were alphahemolytic and sheA positive, 16 carried only sheA, and one carried
sheA and e-hlyA. Also noteworthy was one strain, isolated from
food, that did not grow on SHIBAM but carried the stx1, stx2, eae,
ehxA, and sheA genes. Of the 154 clinical isolates, 95.7% (133/139)
of the hemolytic strains carried stx and/or eae, as opposed to
53.3% (8/15) of the nonhemolytic strains (P ⬍ 0.0001). Of the 200
food isolates, 98.9% (180/182) of the hemolytic strains were stx
and/or eae positive, while 76.5% (13/17) of the nonhemolytic
strains harbored stx only (P ⬍ 0.001). About 86% (38/44) of the
hemolytic strains and only 24% (6/14) of the nonhemolytic strains
isolated from animals were associated with stx and/or eae (P ⬍
0.05). The nine E. coli strains isolated from water were all positive
for sheA only, and four strains showed hemolytic activity. Fourteen strains were isolated from unidentified sources, and seven of
the eight hemolytic strains were positive for stx and/or eae. Of the
six nonhemolytic strains, one strain carried stx2 (Table 4; Fig. 5).
DISCUSSION

Certain E. coli virulence factors, such as Shiga toxin and intimin,
have been well investigated, but the role of hemolysin genes (i.e.,
hlyA, ehxA, and sheA) in E. coli pathogenicity and the association
between these potential virulence factors and stx and eae are
largely unknown. Others have noted that the presence of enterohemolysin (ehxA) is a good epidemiological marker for the presence of Shiga toxin (28, 36) and that at least six different genetic
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FIG 2 Distribution of food isolates to ehxA subtypes and ehxA-negative samples in association with different food products. Values in parentheses are the total
numbers of strains; percentages were calculated based on the total number of food isolates (n ⫽ 200).

ehxA subtypes exist in E. coli (37). To our knowledge, the investigation of hemolysin gene prevalence, as well as ehxA subtype distribution in food isolates compared to clinical and animal isolates
from various geographical locations, has not been previously documented.
One interesting finding from the current study was the variation in ehxA subtype patterns observed between the different categories of isolates (P ⬍ 0.0001). The majority of food isolates
contained ehxA subtype A (64%); however, approximately 20%
did not carry the ehxA gene. Nearly 10% of the food isolates were
associated with ehxA subtype C. In contrast, the clinical isolates
more often carried ehxA subtype C (50%) versus A (10%), while
approximately 25% were ehxA negative. Alternately, the animal
isolates were nearly equally related to ehxA subtypes A and C (each
20%), but about 50% lacked ehxA (Fig. 1 to 3). Importantly, 60%
of the ehxA-negative animal isolates were non-STEC.
Another remarkable finding was the stark contrast in intimin
prevalence rates between food and clinical isolates; the majority of
the food isolates (85%) were associated with eae-negative STEC
strains, while nearly the same proportion (78%) of clinical isolates
carried eae (Table 3). The association of eae-positive clinical STEC
isolates and severe diarrhea and HUS has been noted (2, 19, 66–
68). However, several eae-negative non-O157 STEC strains have
been associated with severe human disease and HUS outbreaks,
e.g., O104:H21 (USA, 1994), O113:H21 (Australia, 1998), and
O104:H4 (Germany, 2011). It is surprising that the overall prevalence patterns for eae and ehxA subtypes obtained from the food
isolates were generally not reflected in the examined clinical iso-
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lates. Although the food isolates investigated in this study did encompass a variety of fresh produce types (e.g., spinach, lettuce,
sprouts) as well as ground beef, they did not represent a survey of
all food products available. In the United States, leafy greens (e.g.,
lettuce and spinach) and ground beef have been important transmission vehicles for human E. coli infections involving E. coli
O157:H7, as well as non-O157 STEC (3–5, 13, 53). While the
USDA recommends that ground beef be cooked to 160°F to destroy pathogens that might be present, including harmful E. coli,
leafy greens are usually consumed raw and possibly with little
cleaning. Thus, any enteric pathogens acquired during growth in
an open agricultural environment might be still present and infectious (11, 14). However, the observation of mostly eae-positive
clinical isolates and eae-negative food isolates has been noted in
several studies and therefore seems to be a general trend (18, 75–
78). It might be that STEC strains carrying ehxA subtype A, strains
which lack the eae gene, generally do not cause severe illness in
infected patients or are mainly associated with sporadic cases;
thus, we have not found this subtype as frequently in clinical isolates, when often a patient is not ill enough to seek medical care.
Another reason for the minority of ehxA subtypes C and F
strains among isolates from food might be the limitation of the
isolation method used. For example, the 67 ground beef isolates
used in this study were isolated by the use of phenotypic characteristics (55). As shown in this study and supported by others,
hemolytic activity as observed on washed sheep blood agar is a
good indicator to identify ehxA-positive STEC (28, 35, 36, 64).
However, in our study, two ehxA-positive isolates, one of which
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FIG 3 Distribution of animal isolates to ehxA subtypes and ehxA-negative samples in association with different animal hosts. Values in parentheses are the total
numbers of strains; percentages were calculated based on the total number of animal isolates (n ⫽ 58).

carried ehxA subtype C and one that carried ehxA subtype A, did
not express hemolytic activity on SHIBAM. In addition, one eae-,
ehxA-positive STEC isolate of ehxA subtype C isolated from food
failed to grow on SHIBAM. Because of their nonhemolytic activity, such colonies might have gone unrecognized in the Bosilevac
et al. study (55). In fact, Bosilevac and colleagues noted an inconsistency between the screening of the enrichment and the culture
results; significantly fewer STEC isolates were obtained from eaeand stx-positive samples than from samples that were only stx
positive (69). This result may explain the higher frequency of eaenegative isolates in food samples. Based on these findings, it is
possible that more eae-positive STEC isolates and correspondingly more subtype C and F strains will be identified in food samples, as improved isolation methods and selective agars for nonO157 STEC are developed.
Three previous studies investigated ehxA subtypes. The study
by Boerlin et al. mainly focused on the evolutionary lineage of
ehxA and noted that ehxA sequences cluster into two main groups
corresponding to the presence or absence of eae, suggesting that
this is due to the evolution of two different virulence plasmids
associated with these strains (70). Newton et al. confirmed the
ehxA phylogeny division into two major clusters and showed that,
in fact, eae-negative strains carry quite a different virulence plasmid than that found in many eae-positive strains (71). We intend
to investigate these findings further by using ehxA-positive isolates
identified in this study. Along with elucidating the finer structure
in the ehxA phylogeny by using RFLP, Cookson and colleagues
identified six ehxA subtypes that clustered into groups of eaenegative (subtype A) and eae-positive (subtype E) strains, eaepositive strains (subtypes B, C, and F), and a third cluster of
eae-negative subtype D strains (37). Sequencing analysis and phylogenetic and pairwise comparison of the ehxA gene in the present
study confirmed the Cookson et al. findings (Fig. 4).
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Cookson et al. also investigated the ehxA subtype prevalence
mainly in sheep and cattle isolates, as well as in 25 clinical isolates,
all of which originated from New Zealand (37). Comparably, we
investigated the ehxA subtype prevalence in a much larger data set:
154 clinical isolates, 200 food isolates, and 58 animal isolates from
various U.S. geographical areas and beyond. While the study by
Cookson and colleagues revealed that clinical isolates carry subtypes C, A, and B in decreasing numbers, the present study additionally identified subtypes E and F, which had not been previously reported (37). The overall predominance of ehxA subtypes A
and C, as well as the strong link between subtypes and eae presence
or absence, were confirmed in the current study (Table 3). We
furthermore validated that ehxA subtypes were closely tied to particular O serogroups (37). For example, ehxA subtype A strains
were closely associated with O8, O22, O88, O91, O113, O116,
O163, and O174 strains, which are less commonly isolated during
outbreaks (1, 6) but represented the most frequently isolated
STEC isolates from food samples in our study. Importantly, O
serogroups O91 and O113 have been linked to human illness in
the past (1, 6, 7, 72), and their presence in the U.S. food supply is
of concern. In contrast, the six serogroups (O26, O45, O103,
O111, O121, and O145) that are most frequently isolated due to
outbreaks (1, 2, 73) and accounted for the majority of the clinical
isolates (64%) in our study were closely associated with ehxA subtypes C and F. Subtype B was exclusively associated with strains of
O serogroup O157. These findings confirmed associations that
may help with the identification of clinically relevant STEC without the need for laborious and expensive serotyping methods. Of
note, Cookson at al. identified a single O121 strain of ehxA subtype B, indicating that subtype B might not be exclusively associated with O157 STEC. This was not confirmed in our study; all
O121 strains were of subtype C.
Most of the strains (87%) analyzed in this study were hemo-
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FIG 4 Phylogenetic relationships of E. coli ehxA sequences from this study, in comparison with sequencing results reported by Cookson et al. (EF204919 to
EF204929) (37). The phylogenetic tree was generated using the neighbor-joining method with MEGA 4.0. Bootstrap values of ⱖ50% are shown at branch points.

lytic, as observed on SHIBAM, and almost all (95%) carried stx
and/or eae. Hemolytic strains carried at least one hemolysin gene;
while e-hlyA (5%) and hlyA (3%) were found less frequently, the
silent hemolysin was widely distributed (94%) among E. coli isolates, as noted previously (48, 74). The majority of the sheA-positive strains carried other hemolysin genes, mainly ehxA; however,
63 hemolytic strains carried only sheA, suggesting that sheA might
be responsible for hemolytic expression. In fact, previous studies
have revealed that sheA is not totally silent in some E. coli strains,
and construction of sheA deletion mutants uncovered a complete

loss of hemolytic activity, indicating a sheA-dependent hemolytic
phenotype (22, 40, 48, 74). The addition of mitomycin C into the
SHIBAM agar used in this study (56) may have further contributed to an increased release of sheA, presumably resulting in detectable levels of hemolytic activity (40). Additionally, anaerobic
conditions during incubation of blood agar plates resulted in increased hemolytic expression due to sheA, and strains that were
nonhemolytic under aerobic conditions expressed hemolytic activity when incubated anaerobically (22). These findings were not
confirmed in our study; most of the strains either did not grow

TABLE 4 Virulence factors in hemolytic and nonhemolytic E. coli strains from clinical, food, animal, and unidentified sources
No. of H and NH strainsa associated with virulence factor(s) that were isolated from indicated source
Clinical (n ⫽ 154)

Food (n ⫽ 199)b

Virulence factor(s)

H

NH

H

stx only
stx and eae
eae only
stx and eae negative

19
103
11
6

3
3
2
7

157
23
0
2

a
b

Animal (n ⫽ 58)

Unidentified
(n ⫽ 14)

NH

H

NH

H

NH

13
0
0
4

16
18
4
6

4
1
1
8

1
5
1
1

1
0
0
5

H, hemolytic; NH, nonhemolytic.
One strain failed to grow on SHIBAM.
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FIG 5 Proportional distribution of hemolytic and nonhemolytic phenotypes within the different categories of isolates, in relation to the presence of at least
one/or no virulence factor (stx1, stx2, eae). Values in parentheses are the total numbers of isolates investigated. (Note: One food isolate failed to grow on
SHIBAM.)

anaerobically, or hemolytic activity was decreased or completely
absent compared to aerobic conditions (unpublished data). The
significance of sheA in pathogenicity of E. coli strains remains
largely unclear. Although sheA is present in highly pathogenic E.
coli strains (e.g., O157:H7 and O104:H4 [Germany, 2011]) and
previous studies have shown the ability of sheA to lyse erythrocytes
and to exhibit cytotoxic and apoptotic activities toward cultured
mammalian cells (41, 42, 46, 49, 50), sheA is also widely spread
among many nonpathogenic E. coli strains. But as shown by Ludwig et al. (48), many strains harbor only mutant sheA derivatives
or fragments therefore of nonfunctional sheA genes. Overall, more
study is necessary to identify the exact role of the silent hemolysin
in E. coli strains. Importantly, data generated in this study established that strains that express hemolytic activity, whether due to
sheA or other hemolysin genes, are significantly more likely (95%)
to be associated with highly deleterious virulence factors (stx, eae)
than nonhemolytic strains (49%) (P ⬍ 0.0001) (Table 4; Fig. 5).
In summary, no apparent association was found between specific ehxA subtypes and a particular clinical outcome or food/
animal source (Fig. 1 to 3). The widely different ehxA subtype
prevalence rates between clinical, food, and animal isolates were
surprising, given that farm animals are natural reservoirs of STEC
and that food, especially fresh produce and ground beef, is an
important transmission vehicle for E. coli infections in humans
(3–5, 11, 12, 13, 53). One would expect similar ehxA subtype patterns between isolates from clinical, animal, and food sources.
However, a linear flow of infection originating from farm animals
and food to ill individuals persists, since we did find all ehxA subtypes more or less in all categories of isolates; also, not all isolates
carried ehxA (Tables 2 and 3). Based on our findings, ehxA subtype

October 2013 Volume 79 Number 20

C and F strains (eae positive), which were predominant in the
clinical isolates (80%) and are associated with O serogroups such
as O26, O45, O103, O111, O121, and O145, are possibly more
frequently linked to severe clinical outcomes than ehxA subtype A
strains (14%; eae negative). Overall, more clinical samples associated with bloody diarrhea, HC, and HUS, as well as a greater
variety of food products, are needed to draw more exact conclusions.
The strong link between ehxA subtypes and eae in STEC makes
it largely possible to distinguish between eae-positive/negative
STEC/E. coli strains by ehxA subtype. Additionally, the close association between particular ehxA subtypes and certain O serogroups, especially O157 and O serogroups that are frequently isolated due to outbreaks, might further contribute to the detection
of clinically important STEC. But further work is needed to refine
ehxA RFLP primers in order to detect all subtypes reliably. Hemolytic activity, as observed on SHIBAM, shows that this medium
generally represents an excellent medium for the isolation of stxand/or eae-positive E. coli strains, regardless of the type of hemolysin gene expressed. In fact, significantly more hemolytic strains
were associated with virulence factors (stx, eae) than nonhemolytic strains (P ⬍ 0.0001) (Table 4; Fig. 5). Overall, sheA and ehxA
were widely distributed among the E. coli isolates tested, while
e-hlyA and hlyA were rarely identified. Further studies are required to investigate the lack of hemolytic expression for the few
ehxA-positive E. coli strains identified in this study.
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